| 000 | 01809 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514223400.0 | ||
| 264 | 0 | _c20051114 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a0969-7128 | ||
| 024 | 7 |
_a10.1038/sj.gt.3302514 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPochampally, R R | |
| 245 | 0 | 0 |
_aCorrection of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. _h[electronic resource] |
| 260 |
_bGene therapy _cJul 2005 |
||
| 300 |
_a1119-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aBone Marrow Cells _xmetabolism |
| 650 | 0 | 4 | _aCalcification, Physiologic |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCollagen Type I _xbiosynthesis |
| 650 | 0 | 4 | _aCollagen Type I, alpha 1 Chain |
| 650 | 0 | 4 |
_aDNA, Complementary _xgenetics |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOsteoblasts _xpathology |
| 650 | 0 | 4 |
_aOsteogenesis Imperfecta _xmetabolism |
| 650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
| 650 | 0 | 4 |
_aProcollagen _xbiosynthesis |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aStromal Cells _xmetabolism |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aHorwitz, E M | |
| 700 | 1 | _aDiGirolamo, C M | |
| 700 | 1 | _aStokes, D S | |
| 700 | 1 | _aProckop, D J | |
| 773 | 0 |
_tGene therapy _gvol. 12 _gno. 14 _gp. 1119-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.gt.3302514 _zAvailable from publisher's website |
| 999 |
_c15485091 _d15485091 |
||